AbbVie ABBV Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $9.39B+79.6% | $5.23B-7.1% | $5.63B-13.0% | $6.47B+25.0% | $5.18B-6.3% | ||
| $12.48B-0.9% | $12.59B-1.4% | $12.77B+1.0% | $12.64B+1.3% | $12.48B+14.3% | ||
| $5.05B+2.0% | $4.95B+0.3% | $4.94B-0.4% | $4.96B+9.6% | $4.53B+8.3% | ||
| $33.53B+15.4% | $29.06B+1.8% | $28.54B-2.5% | $29.26B+5.7% | $27.68B+8.2% | ||
| $5.69B+1.0% | $5.63B+2.6% | $5.48B+3.8% | $5.28B+0.9% | $5.24B+2.0% | ||
| $35.57B-0.2% | $35.64B0.0% | $35.63B0.0% | $35.64B+1.0% | $35.29B+0.9% | ||
| $136.46B+1.9% | $133.96B0.0% | $133.9B-2.4% | $137.18B+0.7% | $136.17B+0.7% | ||
| $0-100% | $2.5B-34.1% | $3.79B-31.8% | $5.56B+249% | $1.59B— | ||
| $0-100% | $2.5B-34.1% | $3.79B— | —— | —— | ||
| $42.1B-2.7% | $43.29B+9.9% | $39.39B-0.9% | $39.77B+9.2% | $36.4B-6.1% | ||
| $18M0.0% | $18M0.0% | $18M0.0% | $18M0.0% | $18M0.0% | ||
| -$17.87B-15.4% | -$15.49B-8.8% | -$14.23B-23.7% | -$11.5B-20.7% | -$9.53B-20.6% | ||
| -$6.66B-104% | -$3.27B-23.8% | -$2.64B-1,344% | -$183M-113% | $1.42B-57.3% | ||
| $136.46B+1.9% | $133.96B0.0% | $133.9B-2.4% | $137.18B+0.7% | $136.17B+0.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are AbbVie's total assets?
- AbbVie (ABBV) holds $136.46B in total assets, up 0.2% year over year.
- How much cash does AbbVie have?
- AbbVie holds $9.4B in cash and equivalents.
- Can AbbVie cover its short-term obligations?
- Its current ratio is 0.80 — current liabilities exceed current assets.
- Where does AbbVie's balance sheet data come from?
- Every line is extracted from AbbVie's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
